HCA

In the past six months, HCA Healthcare's stock price has experienced fluctuations. As of October 8, 2026, HCA shares increased to $446.37, reaching their highest since April 2026. Over the past month, the stock has increased by 6.18%, and over the last three months, it has seen an 8.80% increase. However, year-to-date, the stock had a return of -4.35% as of October 8, 2026, and -7.83% as of October 5, 2026. A notable event impacting the stock price occurred around April 24, 2026, when HCA Healthcare's stock traded sharply lower following its Q1 2026 results. This decline was largely driven by weaker-than-anticipated patient volumes, including a 42% drop in respiratory admissions and a lack of a typical seasonal volume lift, which reduced EBITDA by an estimated $180 million. Additionally, a 15% decline in exchange admissions and a 16% rise in uninsured volumes created an estimated $150 million EBITDA headwind, contributing to investor uncertainty regarding demand trends and reimbursement.